+129.0%
MSI vs GSK
+43.9%
+85.2%
-27.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.5% | -1.2% | +2.7% | +1.7% |
| 7D | +7.7% | -1.1% | +8.8% | +7.9% |
| 30D | +19.9% | +7.8% | +12.1% | +18.0% |
| 3M | +14.9% | +0.3% | +14.6% | +14.7% |
| 6M | +37.2% | +3.4% | +33.8% | +36.0% |
| YTD | +40.8% | +5.9% | +34.9% | +38.3% |
| 1Y | +38.1% | +8.2% | +29.9% | +35.1% |
| 3Y | +77.7% | +65.3% | +12.4% | +54.1% |
| 5Y | +129.0% | +43.3% | +85.7% | +98.9% |
| All | +129.0% | +43.9% | +85.2% | +98.9% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling